Search Results

There are 13493 results for: content related to: Oclacitinib ( APOQUEL ® ) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy

  1. The pharmacokinetics of oclacitinib maleate, a Janus kinase inhibitor, in the dog

    Journal of Veterinary Pharmacology and Therapeutics

    Volume 37, Issue 3, June 2014, Pages: 279–285, W. T. Collard, B. D. Hummel, A. F. Fielder, V. L. King, J. F. Boucher, M. A. Mullins, P. B. Malpas and M. R. Stegemann

    Version of Record online : 16 DEC 2013, DOI: 10.1111/jvp.12087

  2. You have full text access to this OnlineOpen article
    Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis

    Veterinary Dermatology

    Volume 24, Issue 5, October 2013, Pages: 479–e114, Sallie B. Cosgrove, Jody A. Wren, Dawn M. Cleaver, David D. Martin, Kelly F. Walsh, Jessica A. Harfst, Stacey L. Follis, Vickie L. King, Joseph F. Boucher and Michael R. Stegemann

    Version of Record online : 5 JUL 2013, DOI: 10.1111/vde.12047

  3. You have full text access to this OnlineOpen article
    IL-31-induced pruritus in dogs: a novel experimental model to evaluate anti-pruritic effects of canine therapeutics

    Veterinary Dermatology

    Volume 27, Issue 1, February 2016, Pages: 34–e10, Andrea J. Gonzales, Timothy J. Fleck, William R. Humphrey, Betsy A. Galvan, Michelle M. Aleo, Sean P. Mahabir, Jezaniah-Kira Tena, Karen G. Greenwood and Robert B. McCall

    Version of Record online : 15 DEC 2015, DOI: 10.1111/vde.12280

  4. You have full text access to this OnlineOpen article
    A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client-owned dogs with atopic dermatitis

    Veterinary Dermatology

    Volume 24, Issue 6, December 2013, Pages: 587–e142, Sallie B. Cosgrove, Jody A. Wren, Dawn M. Cleaver, Kelly F. Walsh, Stacey I. Follis, Vickie I. King, Jezaniah-Kira S. Tena and Michael R. Stegemann

    Version of Record online : 21 NOV 2013, DOI: 10.1111/vde.12088

  5. JAK1 N-terminus binds to conserved box 1 and box 2 motifs of cytokine receptor common β subunit but signal activation requires JAK1 C-terminus

    Journal of Cellular Biochemistry

    Volume 99, Issue 4, 1 November 2006, Pages: 1078–1084, Huei-Mei Huang, Ya-Li Lee and Ting-Wei Chang

    Version of Record online : 9 JUN 2006, DOI: 10.1002/jcb.20942

  6. You have full text access to this OnlineOpen article
    Repeated oral dose tolerance in dogs treated concomitantly with ciclosporin and oclacitinib for three weeks

    Veterinary Dermatology

    Volume 27, Issue 1, February 2016, Pages: 22–e7, Alessandro Panteri, Günther Strehlau, Rainer Helbig, Christine Prost and Kelly Doucette

    Version of Record online : 11 DEC 2015, DOI: 10.1111/vde.12278

  7. You have full text access to this OnlineOpen article
    A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs

    Veterinary Dermatology

    Volume 26, Issue 1, February 2015, Pages: 23–e8, Peter R. Little, Vickie L. King, Kylie R. Davis, Sallie B. Cosgrove and Michael R. Stegemann

    Version of Record online : 12 DEC 2014, DOI: 10.1111/vde.12186

  8. You have free access to this content
    A region encompassing the FERM domain of Jak1 is necessary for binding to the cytokine receptor gp130

    FEBS Letters

    Volume 505, Issue 1, September 07, 2001, Pages: 87–91, Catharien M.U. Hilkens, Hayaatun Is'harc, Björn F. Lillemeier, Birgit Strobl, Paul A. Bates, Iris Behrmann and Ian M. Kerr

    Version of Record online : 20 AUG 2001, DOI: 10.1016/S0014-5793(01)02783-1

  9. You have free access to this content
    Asymmetrical allocation of JAK1 mRNA during spermatogonial stem cell division in Xenopus laevis

    Development, Growth & Differentiation

    Volume 57, Issue 5, June 2015, Pages: 389–399, Keiichiro Hyakutake, Toshihiro Kawasaki, JiDong Zhang, Hiroshi Kubota, Sin-Ichi Abe and Kazufumi Takamune

    Version of Record online : 19 MAY 2015, DOI: 10.1111/dgd.12219

  10. Generation of Janus kinase 1 (JAK1) conditional knockout mice

    genesis

    Volume 54, Issue 11, November 2016, Pages: 582–588, Kazuhito Sakamoto, Barbara L. Wehde, Patrick D. Rädler, Aleata A. Triplett and Kay-Uwe Wagner

    Version of Record online : 19 OCT 2016, DOI: 10.1002/dvg.22982

  11. The frequency of urinary tract infection and subclinical bacteriuria in dogs with allergic dermatitis treated with oclacitinib: a prospective study

    Veterinary Dermatology

    Andrew C. Simpson, Jennifer R. Schissler, Rod A.W. Rosychuk and A Russell Moore

    Version of Record online : 17 MAY 2017, DOI: 10.1111/vde.12450

  12. Janus kinases in immune cell signaling

    Immunological Reviews

    Volume 228, Issue 1, March 2009, Pages: 273–287, Kamran Ghoreschi, Arian Laurence and John J. O’Shea

    Version of Record online : 6 MAR 2009, DOI: 10.1111/j.1600-065X.2008.00754.x

  13. A case of presumed autoimmune subepidermal blistering dermatosis treated with oclacitinib

    Veterinary Dermatology

    Estelle Aymeric and Emmanuel Bensignor

    Version of Record online : 20 JUN 2017, DOI: 10.1111/vde.12458

  14. JAK/STAT Signalling and Haematological Malignancies

    Standard Article

    eLS

    Stefan N Constantinescu and William Vainchenker

    Published Online : 15 OCT 2015, DOI: 10.1002/9780470015902.a0024988

  15. Signaling Through JAKs and STATs: Interferons Lead the Way

    Standard Article

    Reviews in Cell Biology and Molecular Medicine

    Christian Schindler and Jessica Melillo

    Published Online : 15 SEP 2006, DOI: 10.1002/3527600906.mcb.200500070

  16. Simultaneous activation of JAK1 and JAK2 confers IL-3 independent growth on Ba/F3 pro-B cells

    Journal of Cellular Biochemistry

    Volume 96, Issue 2, 1 October 2005, Pages: 361–375, Huei-Mei Huang, Yi-Li Lin, Cheng-Hsien Chen and Ting-Wei Chang

    Version of Record online : 29 JUN 2005, DOI: 10.1002/jcb.20513

  17. SHP-1 suppresses cancer cell growth by promoting degradation of JAK kinases

    Journal of Cellular Biochemistry

    Volume 90, Issue 5, 1 December 2003, Pages: 1026–1037, Chengyu Wu, Qin Guan, Yingjian Wang, Z. Joe Zhao and G. Wayne Zhou

    Version of Record online : 30 OCT 2003, DOI: 10.1002/jcb.10727

  18. Identification of 8-Hydroxyquinoline Derivatives Active Against Somatic V658F Mutant JAK1-Dependent Cells

    Archiv der Pharmazie

    Volume 349, Issue 12, December 2016, Pages: 925–933, Róbert Kiss, Dávid Bajusz, Rebekah Baskin, Katalin Tóth, Katalin Monostory, Peter P. Sayeski and György M. Keserű

    Version of Record online : 10 NOV 2016, DOI: 10.1002/ardp.201600246

  19. You have free access to this content
    Janus kinases 1 and 2 regulate chemokine-mediated integrin activation and naïve T-cell homing

    European Journal of Immunology

    Volume 43, Issue 7, July 2013, Pages: 1745–1757, Gema Pérez-Rivero, Graciela Cascio, Silvia Fernández Soriano, Álvaro Gil Sanz, Julia Sáez de Guinoa, José Miguel Rodríguez-Frade, Rosa P. Gomariz, Borja L. Holgado, Carlos Cabañas, Yolanda R. Carrasco, Jens V. Stein and Mario Mellado

    Version of Record online : 17 MAY 2013, DOI: 10.1002/eji.201243178

  20. You have full text access to this OnlineOpen article
    A blinded, randomized, placebo-controlled, dose determination trial of lokivetmab (ZTS-00103289), a caninized, anti-canine IL-31 monoclonal antibody in client owned dogs with atopic dermatitis

    Veterinary Dermatology

    Volume 27, Issue 6, December 2016, Pages: 478–e129, Gina M. Michels, Deborah S. Ramsey, Kelly F. Walsh, Olivier M. Martinon, Sean P. Mahabir, Jacquelien D. Hoevers, Rodney R. Walters and Steven A. Dunham

    Version of Record online : 19 SEP 2016, DOI: 10.1111/vde.12376